CRMD
NASDAQ · Pharmaceuticals
Cormedix Inc
$7.90
+0.12 (+1.54%)
Open$8.05
Previous Close$7.78
Day High$8.20
Day Low$7.82
52W High$13.02
52W Low$6.13
Volume—
Avg Volume819.7K
Market Cap606.41M
P/E Ratio3.24
EPS$2.10
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+564.6% upside
Current
$7.90
$7.90
Target
$52.50
$52.50
$41.99
$52.50 avg
$66.46
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 305.28M | 151.82M | 142.81M |
| Net Income | 159.69M | 25.07M | 23.58M |
| Profit Margin | 52.3% | 16.5% | 16.5% |
| EBITDA | 147.71M | 47.08M | 40.68M |
| Free Cash Flow | — | 14.58M | 22.25M |
| Rev Growth | +1,545.2% | +9.9% | -6.7% |
| Debt/Equity | 0.36 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,148.51 | -1.85% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $267.76 | -0.53% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $147.66 | -2.15% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $28.05 | +0.43% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.77 | -1.50% | 11.5 | 30.15B |